* NextGen Healthcare Inc NXGN.OQ NXGN.O is expected to show
a rise in quarterly revenue when it reports results on July 29.
* The Atlanta, Georgia-based company is expected to report a
6.8% increase in revenue to $139.747 million from $130.88
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NextGen Healthcare Inc
is for earnings of 21 cents per share. For the same quarter last
year, the company reported earnings of 21 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 3 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.2% in the last three months.
* Wall Street's median 12-month price target for NextGen
Healthcare Inc is $21, about 23.2% above its last closing
price of $16.12.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.19 0.19 0.21 Beat 8.8
Dec. 31 2020 0.24 0.25 0.26 Beat 5.4
Sep. 30 2020 0.20 0.20 0.30 Beat 48.5
Jun. 30 2020 0.08 0.08 0.21 Beat 152
Mar. 0.19 0.19 0.20 Beat 3
31 2020
Dec. 31 2019 0.20 0.20 0.23 Beat 15.2
Sep. 30 2019 0.23 0.23 0.24 Beat 4.5
Jun. 30 2019 0.21 0.21 0.16 Missed -22.6
This summary was machine generated July 27 at 20:24 GMT. All
figures in US dollars unless otherwise stated